This led us to suggest LVSELs as pluripotent cells that might contribute to malignant hematopoiesis and endeavored to follow BCR-ABL expression in blood-circulating stem cells from CML patients. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.